An Update on the Current State of Management and Clinical Trials for IgA Nephropathy

An Update on the Current State of Management and Clinical Trials for IgA Nephropathy

IgA nephropathy remains the most common primary glomerular disease worldwide. It affects children and adults of all ages, and is a leading cause of end-stage kidney disease, making it a considerable public health issue in many countries. Despite being initially described over 50 years ago, there are...

Full description

Bibliographic Details
Main Authors: Chee Kay Cheung, Arun Rajasekaran, Jonathan Barratt, Dana V. Rizk
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Journal of Clinical Medicine
Subjects:
IgA
IgA nephropathy
clinical trials
Online Access:https://www.mdpi.com/2077-0383/10/11/2493

Similar Items

Similar Items